Elizabeth O’Donnell

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.5K citations

Hematological Malignancy, Cell Therapy, Immunotherapy +11

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja et al. · Journal of Clinical Oncology · 2022 · 580 citations · Full text

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 348 citations · Full text

Hematological Malignancy, Proteasome Inhibitors, Relapsed Myeloma +10

The E3 Ubiquitin Ligase Activity of <i>Arabidopsis</i> PLANT U-BOX17 and Its Functional Tobacco Homolog ACRE276 Are Required for Cell Death and Defense

Chengwei Yang, Rocío González-Lamothe, Richard Ewan et al. · The Plant Cell · 2006 · 236 citations · Full text

Plant Molecular Biology, Plant Immunity, Plant Gene Expression +15

Small Ubiquitin-Like Modifier Proteases OVERLY TOLERANT TO SALT1 and -2 Regulate Salt Stress Responses in <i>Arabidopsis</i>

Lucio Conti, Gillian Price, Elizabeth O’Donnell et al. · The Plant Cell · 2008 · 188 citations · Full text